UPDATE : Tuesday, April 24, 2018
상단여백
Yungjin’s new drug completes phase 2a clinical trial in US
Yungjin Pharmaceutical has secured the safety of “YPL-001,” a new drug to t...
by Lee Hye-seon  |  2017-08-03 15:42
라인
365mc, Microsoft Korea to create liposuction AI system
365mc Networks has signed a contract with Microsoft Korea한국마이크로소프트 for the ...
by Constance Williams  |  2017-08-03 14:54
라인
Phase 3 clinical trials for new schizophrenia drug
Bukwang Pharmaceutical will enter into phase 3 clinical trials of Lurasidon...
by Lee Hye-seon  |  2017-08-03 14:53
라인
Healthcare big data show limits as basis of research
Big data provided by National Health Insurance Service(NHIS) and Health Ins...
by Nam Doo-hyun  |  2017-08-03 12:38
라인
Korea’s hospital information system exported to US
A consortium of Seoul National University Bundang Hospital분당서울대병원 (SNUBH), ...
by Constance Williams  |  2017-08-03 11:59
라인
FDA approves Imbruvica treat chronic GVHD
The U.S. Food and Drug Administration (FDA) Wednesday expanded the approval...
by Constance Williams  |  2017-08-03 10:32
라인
Pharmaceuticals stage fierce competition over composite drugs
Korean pharmaceutical companies are focusing their attention on the develop...
by Lee Hye-seon  |  2017-08-02 17:01
라인
Samsung registers patent for portable blood pressure gauge
Samsung Electronics has recently registered a patent for its portable blood...
by Nam Doo-hyun  |  2017-08-02 16:28
라인
Will Inha University Hospital’s challenge succeed?
A year has passed since some hospitals ran pilot programs of the hospitalis...
by Yang Geum-deok  |  2017-08-02 14:30
라인
UNIST to develop next-generation AI technology
The government has selected Ulsan National Institute of Science and Technol...
by Marian Chu  |  2017-08-02 11:07
라인
‘I want YuYu to be a dream workplace for employees’
Salespeople are the most stressed group at most business corporations. Nowh...
by Constance Williams  |  2017-08-02 11:06
라인
Celgene’s leukemia drug wins FDA approval
The U.S. Food and Drug Administration Tuesday approved Idhifa (compound: en...
by Constance Williams  |  2017-08-02 10:31
라인
MSD gets approval to expand Januvia label
MSD Korea said Tuesday that its Januvia (ingredient name: Citigliptin), Jan...
by Constance Williams  |  2017-08-01 17:37
라인
Regulators to add liver damage risks to antiobestic drug
Antiobestic drug Contrav ER Tab. (compound: naltrexon/bupropion), imported ...
by Lee Hye-seon  |  2017-08-01 17:21
라인
Hospitals to introduce ‘15-minute consultation’ program
Korean patients visiting large university hospitals used to wait for three ...
by Marian Chu  |  2017-08-01 16:53
라인
Celltrion’s biosimilar takes 30% of Europe market share
Celltrion’s second antibody biosimilar product in Europe, Truxima, has regi...
by Constance Williams  |  2017-08-01 16:31
라인
5 universities publish most papers in prestigious bio journals
Which university has published the largest number of bio-related research p...
by Nam Doo-hyun  |  2017-08-01 16:18
라인
Health authorities to reflect climate change effects on policy
The Ministry of Health and Welfare has worked out details, including evalua...
by Marian Chu  |  2017-08-01 15:51
라인
LG’s development of composite drug gains momentum
The development of the ‘Gemigliptin+Rosuvastatin’ complex developed by LG C...
by Lee Hye-seon  |  2017-08-01 15:24
라인
Lilly’s Lartruvo to hit domestic market
Lilly Korea said Tuesday it would release an advanced soft tissue sarcoma t...
by Constance Williams  |  2017-08-01 14:03
여백
여백
여백
Back to Top